A detailed history of New York Life Investment Management LLC transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, New York Life Investment Management LLC holds 311,304 shares of BMY stock, worth $18 Million. This represents 0.17% of its overall portfolio holdings.

Number of Shares
311,304
Previous 321,185 3.08%
Holding current value
$18 Million
Previous $13.3 Million 20.78%
% of portfolio
0.17%
Previous 0.14%

Shares

10 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 07, 2024

SELL
$39.66 - $51.75 $391,880 - $511,341
-9,881 Reduced 3.08%
311,304 $16.1 Million
Q2 2024

Aug 05, 2024

BUY
$40.25 - $52.99 $131,255 - $172,800
3,261 Added 1.03%
321,185 $13.3 Million
Q1 2024

May 03, 2024

SELL
$47.98 - $54.4 $544,573 - $617,440
-11,350 Reduced 3.45%
317,924 $17.2 Million
Q4 2023

Feb 05, 2024

SELL
$48.48 - $57.85 $268,870 - $320,836
-5,546 Reduced 1.66%
329,274 $16.9 Million
Q3 2023

Nov 07, 2023

SELL
$57.89 - $64.73 $251,589 - $281,316
-4,346 Reduced 1.28%
334,820 $19.4 Million
Q2 2023

Aug 04, 2023

SELL
$63.71 - $70.74 $150,228 - $166,804
-2,358 Reduced 0.69%
339,166 $21.7 Million
Q1 2023

May 08, 2023

BUY
$65.71 - $74.53 $50,333 - $57,089
766 Added 0.22%
341,524 $23.7 Million
Q4 2022

Feb 10, 2023

SELL
$68.48 - $81.09 $6,300 - $7,460
-92 Reduced 0.03%
340,758 $24.5 Million
Q3 2022

Nov 10, 2022

BUY
$0.13 - $76.84 $56 - $33,118
431 Added 0.13%
340,850 $24.2 Million
Q2 2022

Aug 12, 2022

BUY
$72.62 - $79.98 $24.7 Million - $27.2 Million
340,419 New
340,419 $26.2 Million

Others Institutions Holding BMY

About BRISTOL MYERS SQUIBB CO


  • Ticker BMY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,126,160,000
  • Market Cap $123B
  • Description
  • Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...
More about BMY
Track This Portfolio

Track New York Life Investment Management LLC Portfolio

Follow New York Life Investment Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of New York Life Investment Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on New York Life Investment Management LLC with notifications on news.